Form 4: Madrigal Pharmaceuticals Director Fred B. Craves Reports Gift of Shares
SEC Form 4 Filing
Director Fred B. Craves reported gifting shares of Madrigal Pharmaceuticals stock on June 11, 2024.
Summary
- On June 11, 2024, Fred B. Craves, a director of Madrigal Pharmaceuticals, reported gifting 39,000 shares of common stock.
- He also gifted 45,852 shares of common stock held indirectly through a grantor retained annuity trust.
- Following these transactions, Craves directly owns 374,362 shares of common stock.
- He also indirectly owns 11,210 shares through a grantor retained annuity trust, 1,261 shares through Bay City Capital LLC, and 18,000 shares through the Craves Family Foundation.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing regarding stock transactions. It doesn't convey any particular positive or negative sentiment about the company's performance or prospects.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider and doesn't necessarily reflect a broader trend in the pharmaceutical industry.
Stakeholder Impact
- The gifting of shares by a director could be perceived differently by stakeholders; some may see it as a charitable act, while others might analyze the reasons behind the transaction.
Key Dates
| Date | Description |
|---|---|
| 06/11/2024 | Date of the reported transactions (gifting of shares). |
| 06/13/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.